Many driver mutations in cancer are specific in that they occur at significantly higher rates than - presumably - functionally alternative mutations. For example, V600E in the BRAF hydrophobic activation segment (AS) pocket accounts for >95% of all kinase mutations. While many hypotheses tried to explain such significant mutation patterns, conclusive explanations are lacking. Here, we use experimental and in silico structure-energy statistical analyses, to elucidate why the V600E mutation, but no other mutation at this, or any other positions in BRAF's hydrophobic pocket, is predominant. We find that BRAF mutation frequencies depend on the equilibrium between the destabilization of the hydrophobic pocket, the overall folding energy, the act...
Different genetic aberrations of BRAF have been reported in various malignancies. BRAF is member of ...
Background: Genes in the Ras pathway have somatic mutations in at least 60 % of colorectal cancers. ...
BRAF represents one of the most frequently mutated protein kinase genes in human tumours. The mutati...
The BRAF kinase is attracting a lot of attention in oncology as alterations of its amino acid sequen...
BRAF is a component of the RAF/MEK/ERK signalling cascade which controls fundamental cellular activi...
Gene mutations can induce cellular alteration and malignant transformation. Development of many type...
Mutation of BRAF at the valine 600 residue occurs in approximately 10% of colorectal cancers, a grou...
Background/Aim: The murine sarcoma viral (V-Raf) oncogene homolog B (BRAF) V600E mutation, which inc...
The BRAF kinase is attracting a lot of attention in oncology as alterations of its amino acid sequen...
Various types of human cancers harbor BRAF somatic mutations, leading researchers to seek molecular ...
Background: Colorectal cancer represents the most prevalent gastrointestinal malignancy. Prognosis o...
The BRAF oncogene is an integral component of the MAP kinase pathway, and an activating V600E mutati...
The BRAF oncogene is an integral component of the MAP kinase pathway, and an activating V600E mutati...
International audienceThe BRAF proto-oncogene serine/threonine-protein kinase, known as BRAF, belong...
To assess the mutational status of BRAF in FVPTC, we directly sequenced the genomic DNA of 30 primar...
Different genetic aberrations of BRAF have been reported in various malignancies. BRAF is member of ...
Background: Genes in the Ras pathway have somatic mutations in at least 60 % of colorectal cancers. ...
BRAF represents one of the most frequently mutated protein kinase genes in human tumours. The mutati...
The BRAF kinase is attracting a lot of attention in oncology as alterations of its amino acid sequen...
BRAF is a component of the RAF/MEK/ERK signalling cascade which controls fundamental cellular activi...
Gene mutations can induce cellular alteration and malignant transformation. Development of many type...
Mutation of BRAF at the valine 600 residue occurs in approximately 10% of colorectal cancers, a grou...
Background/Aim: The murine sarcoma viral (V-Raf) oncogene homolog B (BRAF) V600E mutation, which inc...
The BRAF kinase is attracting a lot of attention in oncology as alterations of its amino acid sequen...
Various types of human cancers harbor BRAF somatic mutations, leading researchers to seek molecular ...
Background: Colorectal cancer represents the most prevalent gastrointestinal malignancy. Prognosis o...
The BRAF oncogene is an integral component of the MAP kinase pathway, and an activating V600E mutati...
The BRAF oncogene is an integral component of the MAP kinase pathway, and an activating V600E mutati...
International audienceThe BRAF proto-oncogene serine/threonine-protein kinase, known as BRAF, belong...
To assess the mutational status of BRAF in FVPTC, we directly sequenced the genomic DNA of 30 primar...
Different genetic aberrations of BRAF have been reported in various malignancies. BRAF is member of ...
Background: Genes in the Ras pathway have somatic mutations in at least 60 % of colorectal cancers. ...
BRAF represents one of the most frequently mutated protein kinase genes in human tumours. The mutati...